Previous Section
Review Articles
1. Effects of statins, fibrates, rosuvastatin, and ezetimibe beyond cholesterol: the modulation of LDL size and subclasses in high-risk patients.
- Author
- Rizzo M; Rini GB; Berneis K;
- Institution
- Department of Clinical Medicine and Emerging Diseases, University of Palermo, Italy. mrizzo@unipa.it
- Journal
- Adv Ther. 2007 May-Jun;24(3):575-82.
- Abstract URL
- Click here to view abstract
2. Measuring cholesterol levels.
- Author
- Pottle A;
- Institution
- Harefield Hospital, Harefield, Middlesex. a.pottle@rbht.nhs.uk
- Journal
- Nurs Stand. 2007 Jul 25-31;21(46):42-7.
- Abstract URL
- Click here to view abstract
3. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
- Author
- Alsheikh-Ali AA; Maddukuri PV; Han H; Karas RH;
- Institution
- Molecular Cardiology Research Institute and Division of Cardiology, Department of Medicine, Tufts-New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111, USA.
- Journal
- J Am Coll Cardiol. 2007 Jul 31;50(5):409-18. Epub 2007 Jul 16.
- Abstract URL
- Click here to view abstract
4. Ezetimibe: an update on the mechanism of action, pharmacokinetics and recent clinical trials.
- Author
- Sweeney ME; Johnson RR;
- Institution
- Emory University School of Medicine, Division of Endocrinology, Metabolism and Lipids, Atlanta VA Medical Center-111, 1670 Clairmont Rd, Atlanta, GA 30033, USA. msweene@emory.edu
- Journal
- Expert Opin Drug Metab Toxicol. 2007 Jun;3(3):441-50.
- Abstract URL
- Click here to view abstract
5. Complementary therapy to target LDL cholesterol: the role of the ezetimibe/simvastatin combination.
- Author
- Neal RC; Jones PH;
- Institution
- Baylor College of Medicine, Section of Lipid and Atherosclerosis, Houston, TX 77030, USA. rneal@bcm.tmc.edu
- Journal
- Vasc Health Risk Manag. 2006;2(1):31-8.
- Abstract URL
- Click here to view abstract
6. Plant sterols as dietary adjuvants in the reduction of cardiovascular risk: theory and evidence.
- Author
- Patch CS; Tapsell LC; Williams PG; Gordon M;
- Institution
- National Centre of Excellence in Functional Foods, Northfields Avenue, University of Wollongong, New South Wales, Australia. cpatch@nceff.com.au
- Journal
- Vasc Health Risk Manag. 2006;2(2):157-62.
- Abstract URL
- Click here to view abstract
7. Nutriceuticals in cardiovascular disease: psyllium.
- Author
- Petchetti L; Frishman WH; Petrillo R; Raju K;
- Institution
- Department of Medicine, Mt. Vernon Hospital, Mt. Vernon, New York, USA.
- Journal
- Cardiol Rev. 2007 May-Jun;15(3):116-22.
- Abstract URL
- Click here to view abstract
8. Dietary plant sterols and cholesterol metabolism.
- Author
- Ellegard LH; Andersson SW; Normen AL; Andersson HA;
- Institution
- Department of Clinical Nutrition, Sahlgrenska Academy at Goteborg University, Box 459, SE-413 90 Goteborg, Sweden Lasse.Ellegard@nutrition.gu.se
- Journal
- Nutr Rev. 2007 Jan;65(1):39-45.
- Abstract URL
- Click here to view abstract
9. The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials.
- Author
- Coleman CI; Reinhart K; Kluger J; White CM;
- Institution
- Journal
- Curr Med Res Opin. 2008 May;24(5):1359-62. Epub 2008 Apr 1.
- Abstract URL
- Click here to view abstract
10. Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk.
- Author
- Knopp RH; Paramsothy P; Atkinson B; Dowdy A;
- Institution
- Division of Metabolism, Endocrinology and Nutrition, Northwest Lipid Research Clinic, Seattle, Washington, USA. rhknopp@u.washington.edu
- Journal
- Am J Cardiol. 2008 Apr 17;101(8A):48B-57B.
- Abstract URL
- Click here to view abstract
